Cordlife and Artivision unveil placement plans
The former expects to raise $32.1m from private placement and the latter $4.27m
Add BT as a preferred source
CORDLIFE Group and Artivision Technologies yesterday announced that they are raising funds via share placements.
Cordlife has proposed a private placement of 26.8 million shares that is expected to raise gross proceeds of $33.5 million. After deducting fees and expenses, the group expects to raise net proceeds of $32.1 million.
Cordlife, which runs a cord blood bank, intends to offer 17.8 million shares at $1.25 each via placement agent United Overseas Bank, while the remaining 9.038 million shares will be taken up by Caerus Capital and four other investors via subscription agreements.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Manulife pulls loan product for rich Hong Kong clients after scrutiny
